Prot# CELC200A2401/2939107: A Long-Term, Double-Blind, Randomized, Parallel-Group, Carbidopa/Levodopa Controlled, Multi-Center Study to Evaluate the Effect of Stalevo in Patients with Parkinson's Disease Requiring Initiation of Levodopa Therapy

Project: Research project

Project Details

StatusFinished
Effective start/end date7/1/04 → 7/15/09

Funding

  • PRA Health Sciences (CELC200A2401 // 2939107)
  • Novartis Pharmaceuticals Corporation (CELC200A2401 // 2939107)